Free Trial
LON:SXS

Spectris (SXS) Share Price, News & Analysis

Spectris logo
GBX 4,104 +2.00 (+0.05%)
As of 12:18 PM Eastern

About Spectris Stock (LON:SXS)

Advanced

Key Stats

Today's Range
4,100
4,108
50-Day Range
4,030
4,110
52-Week Range
1,877
4,170
Volume
617,944 shs
Average Volume
1.05 million shs
Market Capitalization
£4.08 billion
P/E Ratio
71.25
Dividend Yield
0.02%
Price Target
GBX 3,573.50
Consensus Rating
Moderate Buy

Company Overview

Receive SXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Spectris and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SXS Stock News Headlines

Spectris plc Updates on Total Voting Rights
Buy alert: Move $1,000 before Tesla’s Optimus launch
Elon's $1,000,000,000,000 payday Elon Musk just made his biggest insider purchase of Tesla stock ever. He's preparing for a "mind blowing" new launch that could see Tesla move away from electric cars... and into a new market.tc pixel
See More Headlines

SXS Stock Analysis - Frequently Asked Questions

Spectris' stock was trading at GBX 2,508 at the beginning of the year. Since then, SXS shares have increased by 63.6% and is now trading at GBX 4,104.

Spectris plc (LON:SXS) announced its quarterly earnings data on Thursday, August, 7th. The company reported $38.40 earnings per share (EPS) for the quarter. Spectris had a trailing twelve-month return on equity of 20.13% and a net margin of 20.44%.
Read the conference call transcript
.

Shares of SXS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Spectris investors own include Eiger BioPharmaceuticals (EIGR), Abcam (ABC), Danaher (DHR), Intel (INTC), Rotork (ROR), Tesla (TSLA) and AltaGas (ALA).

Company Calendar

Last Earnings
8/07/2025
Today
10/23/2025

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Scientific & Technical Instruments
Sub-Industry
N/A
Current Symbol
LON:SXS
CIK
N/A
Fax
N/A
Employees
7,266
Year Founded
N/A

Price Target and Rating

High Price Target
GBX 4,147
Low Price Target
GBX 3,000
Potential Upside/Downside
-12.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
GBX 57.60
Trailing P/E Ratio
71.22
Forward P/E Ratio
21.06
P/E Growth
2.74
Net Income
£270.93 million
Net Margins
20.44%
Pretax Margin
N/A
Return on Equity
20.13%
Return on Assets
5.42%

Debt

Debt-to-Equity Ratio
4.37
Current Ratio
2.36
Quick Ratio
1.03

Sales & Book Value

Annual Sales
£1.35 billion
Price / Sales
3.03
Cash Flow
GBX 143.90 per share
Price / Cash Flow
28.51
Book Value
GBX 1,397.02 per share
Price / Book
2.94

Miscellaneous

Outstanding Shares
99,351,000
Free Float
N/A
Market Cap
£4.08 billion
Optionable
Not Optionable
Beta
0.61
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (LON:SXS) was last updated on 10/23/2025 by MarketBeat.com Staff
From Our Partners